rs11257600 - CDC123

Magnitude 2.2 · 2 studies on file

Reported associations

  • Genome-wide association study of cardiometabolic multimorbidity in the UK Biobank. - Clinical genetics (2024) · Zhao C, Ma T, Cheng X, Zhang G, Bai Y · PubMed 38409652

    Considering the high prevalence and poor prognosis of cardiometabolic multimorbidity (CMM), identifying causal factors and actively implementing preventive measures is crucial. However, Mendelian randomization (MR), a key method for identifying the causal factors of CMM, requires knowledge of the effects of SNPs on CMM, which remain unknown. We first analyzed the genetic overlap of single cardiometabolic diseases (CMDs) using the latest genome-wide association study (GWAS) for evidential support and comparison. We observed strong positive genetic correlations and shared loci among all CMDs. Further, GWAS and post-GWAS analyses of CMM were performed in 407 949 European ancestry individuals from the UK Biobank. Eleven loci and 12 lead SNPs were identified. By comparison, we found these SNP

  • Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls - Unknown journal (n.d.) · Unknown authors · PubMed 31118516

    ABSTRACT: Protein-coding genetic variants that strongly affect disease risk can yield relevant clues to disease pathogenesis. Here we report exome-sequencing analyses of 20,791 individuals with type 2 diabetes (T2D) and 24,440 non-diabetic control participants from 5 ancestries. We identify gene-level associations of rare variants (with minor allele frequencies of less than 0.5%) in 4 genes at exome-wide significance, including a series of more than 30 SLC30A8 alleles that conveys protection against T2D, and in 12 gene sets, including those corresponding to T2D drug targets (P = 6.1 × 10−3) and candidate genes from knockout mice (P = 5.2 × 10−3). Within our study, the strongest T2D gene-level signals for rare variants explain at most 25% of the heritability of the stron


Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.

Lifestyle context

Concrete actions anchored to the cited research. We do not prescribe, we describe.

Discuss with your doctor

  • Diabetes prevention strategy Moderate

    Genetic predisposition identified; personalized prevention plan recommended

Screening

  • Type 2 diabetes risk monitoring Moderate

    T allele at rs11257600 associated with 1.16-fold increased Type 2 diabetes risk

    Periodic HbA1c and fasting glucose testing